B02.7
Disseminated zoster
Clinical Classification Guidelines
Medical Intelligence & Overview
Disseminated zoster is a severe form of shingles caused by the reactivation of the varicella-zoster virus in the body. Unlike typical shingles, which usually affect a limited area, disseminated zoster involves widespread skin eruptions that can cover large parts of the body. It often occurs in people with weakened immune systems and requires prompt medical attention to prevent complications.
Causes & Symptoms
Clinical Causes: Reactivation of the varicella-zoster virus, which causes both chickenpox and shingles Weakened immune system due to conditions like HIV/AIDS, cancer, or immunosuppressive treatments Age-related decline in immune function, especially in older adults Certain medications that suppress immune responses, such as chemotherapy or corticosteroids Chronic illnesses that compromise immunity
Key Symptoms: Widespread rash with clusters of blisters that may cover large areas of the body Pain, burning, or tingling sensation in affected areas Fever and malaise accompanying skin eruptions General fatigue and discomfort Potential complications such as bacterial infections of the skin, nerve pain (postherpetic neuralgia), or dissemination to internal organs
Diagnostic & Treatment
Diagnosis Path: Diagnosis is mainly clinical, based on the appearance of the skin rash and patient history. A healthcare provider may perform additional tests such as:
Treatment Protocols: Treatment of disseminated zoster involves antiviral medications to reduce viral activity and prevent complications. Common treatments include:
Clinical Advice & FAQs
Billing Guidance
Is B02.7 a billable ICD-10 code?
Yes, B02.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B02.7?
Clinical documentation must specify the nature of Disseminated zoster and any associated comorbidities for accurate reporting.
Cite this Clinical Reference